AC Immune (ACIU) Exchange Rate Effect (2015 - 2026)
AC Immune's (ACIU) quarterly Exchange Rate Effect came in at $8.9 million in Q1 2026, up 3087.69% year-on-year from $280423.5 in Q1 2025, and up 4069.19% on a QoQ basis from -$225210.6 in Q4 2025.
AC Immune (ACIU) Exchange Rate Effect (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has 12 years of Exchange Rate Effect data on file, last reported at $8.9 million in Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 3087.69% year-over-year to $8.9 million in Q1 2026; TTM through Mar 2026 was $8.9 million, a 317.38% increase from a year earlier, with the FY2025 full-year figure at $8.4 million, up 547.98% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $8.9 million, up from -$225210.6 in the prior quarter.
- Over the last five years, Exchange Rate Effect for ACIU reached as high as $50.9 million in Q2 2022 and fell as low as -$3.2 million in Q3 2024.
- Historically, Exchange Rate Effect has averaged $3.1 million across 5 years, with a median of -$18751.6 in 2025.
- On a YoY basis, Exchange Rate Effect climbed as much as 18538.37% in 2024 and fell as far as 5479.72% in 2024.
- Year by year, Exchange Rate Effect stood at -$330091.0 in 2022, then plunged by 429.37% to -$1.7 million in 2023, then surged by 227.19% to $2.2 million in 2024, then plunged by 110.13% to -$225210.6 in 2025, then soared by 4069.19% to $8.9 million in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $8.9 million in Q1 2026, -$225210.6 in Q4 2025, and -$18751.6 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | AC Immune | 222.66 Mn | 222.66 Mn | - | 8.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.94 Mn |
| Mar 31, 2026 | 8.94 Mn |
| Dec 31, 2025 | -225,210.56 |
| Dec 31, 2025 | -225,210.56 |
| Sep 30, 2025 | -18,751.64 |
| Sep 30, 2025 | -18,751.64 |
| Jun 30, 2025 | -2.75 Mn |
| Jun 30, 2025 | -2.75 Mn |
| Mar 31, 2025 | -299,195.39 |
| Mar 31, 2025 | -299,195.39 |
| Dec 31, 2024 | 2.22 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | -3.17 Mn |
| Sep 30, 2024 | -3.17 Mn |
| Jun 30, 2024 | -2.87 Mn |
| Jun 30, 2024 | -2.87 Mn |
| Mar 31, 2024 | 1.99 Mn |
| Mar 31, 2024 | 1.99 Mn |
| Dec 31, 2023 | -1.75 Mn |
| Dec 31, 2023 | -1.75 Mn |